B2B SaaS Provider · vs · MarTech Vendor
Dokkio vs Doximity
Structured technology and market comparison · 2026
Direct Feature Comparison
Dokkio · vs · DoximityAI-powered SaaS for organising and querying distributed work files.
Clinician network and healthcare workflow platform monetised via enterprise tools.
Comparison Analysis
What is the main difference between Dokkio and Doximity?
When comparing Dokkio and Doximity, both platforms operate within the Conversational AI & Chatbots and Chat & Conversational UI ecosystem. Dokkio is positioned as AI-powered SaaS for organising and querying distributed work files, whereas Doximity focuses on Clinician network and healthcare workflow platform monetised via enterprise tools. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Dokkio and Doximity?
When evaluating Dokkio and Doximity, enterprise buyers also consider other platforms in Conversational AI & Chatbots and Chat & Conversational UI. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
Market Signals
Recent Market Signals & Activity: Dokkio vs Doximity
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Dokkio
Recent Signals
No recent market signals documented for Dokkio in the current tracking window.
Doximity
Recent Signals
- ·Doximity
Novant Health Partners with Doximity to Bring Evidence-Based Clinical AI Into Epic
Doximity announces new partnerships with Novant Health and Penn Highlands Healthcare to deploy its Clinical AI Suite, and releases the 2026 Physician Compensation Report highlighting AI fluency as a career advantage.
- ·Doximity
Penn Highlands Healthcare Partners with Doximity to Launch System-Wide Clinical AI Suite
Doximity announces a partnership with Penn Highlands Healthcare to deploy its Clinical AI Suite system-wide.
- ·CNBC InvestingFinancials
Doximity Shares More Than Double After AI Remarks
Shares of Doximity more than doubled in premarket trading after CEO Jeffrey Tangney said the company’s new AI search product generates over ten times the revenue per search versus its cost. Doximity reported fiscal Q1 2027 revenue of $156.6 million and adjusted EBITDA of $74.8 million, both beating estimates, and raised its full-year revenue guidance by $6 million to a range of $671 million–$681 million. Analysts note that the updated guidance likely does not fully incorporate AI search revenue. Elevated short interest (about 17% of float) contributed to a rapid squeeze as positions were unwound. The stock surge followed comments on AI unit economics made on the company’s earnings call.
- Doximity reported fiscal Q1 2027 revenues of $156.6 million and adjusted EBITDA of $74.8 million, both above consensus estimates.
- Doximity raised its full-year 2027 revenue guidance by $6 million to a range of $671 million to $681 million.
- CEO Jeffrey Tangney said the company’s AI search product earns more than 10 times the revenue per search compared with its cost to run.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Dokkio and Doximity share across the market ecosystem.